All these tools Exscientia , GPT4All offer flexible pricing models suitable for Founders & Startups seeking AI-powered solutions to enhance their AI Slideshows efforts.
Exscientia
GPT4All
- Starter - Free
- Pro - $10 /month
- Team - $125 /seat /month
- Enterprise - Contact Sales
These AI tools are among the best AI Slideshows tools available in 2026. For Founders & Startups, tools like Exscientia , GPT4All help streamline the AI Slideshows process by offering AI-powered features.
What is Exscientia?
Exscientia, founded in 2012 in Oxford, UK, is a trailblazing AI-driven drug discovery platform for precision medicine that leverages artificial intelligence to revolutionize pharmaceutical development. Acquired by Recursion Pharmaceuticals in November 2024, Exscientia combines AI, automation, and patient-centric data to design safer, more effective drugs faster. With over $450 million in milestone payments and a pipeline of more than 10 clinical and preclinical programs, patient-first AI for drug development has delivered the first three AI-designed drugs to clinical trials, achieving 10 times productivity gains. Trusted by partners like Sanofi and Bristol Myers Squibb, Exscientia operates globally, focusing on oncology and beyond.
What is GPT4All?
GPT4All is an open-source project built with privacy and security, run by Nomic AI. GPT4All allows users to run large language models (LLMs) locally on their own hardware without an internet connection. GPT4All supports LLaMa, Mistral, Nous-Hermes, and more than 1000 open-source language models.
-
Accuracy and Reliability:
4.7
-
Cost-Efficiency:
4.5
-
Customization and Flexibility:
4.8
-
Data Privacy and Security:
4.6
-
Ease of Use:
4.5
-
Functionality and Features:
4.4
-
Integration Capabilities:
4.3
-
Performance and Speed:
4.2
-
Support and Resources:
4.7
-
Accuracy and Reliability:
4.9
-
Cost-Efficiency:
4.8
-
Customization and Flexibility:
4.9
-
Data Privacy and Security:
4.9
-
Ease of Use:
4.9
-
Functionality and Features:
4.9
-
Integration Capabilities:
4.8
-
Performance and Speed:
4.9
-
Support and Resources:
4.9
Exscientia
10x faster drug discovery.
95% accurate drug response predictions.
30% cost reduction in R&D.
Scalable AWS-powered platform.
Strong partnerships with Sanofi and Merck.
Requires technical expertise.
Minor third-party data privacy risks.
High initial costs for small firms.
Occasional support delays.
GPT4All
Privacy-focused and local
Supports various hardware
Customizable chat experience
Wide range of open-source models
No internet required
Limited to local device capacity
May require technical expertise
Large Models can be resource-intensive
Enterprise features require licensing
- Exscientia
- Oxford, UK
- Nomic AI
- Newyork